Novavax (NVAX) Net Margin Growth (1y) (2011 - 2026)
Novavax (NVAX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
-8,460.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-8,460.00 |
| Dec 31, 2025 |
10,367.00 |
| Sep 30, 2025 |
-14,376.00 |
| Jun 30, 2025 |
2,178.00 |
| Mar 31, 2025 |
23,501.00 |
| Dec 31, 2024 |
-3,053.00 |
| Sep 30, 2024 |
-7,359.00 |
| Jun 30, 2024 |
2,541.00 |
| Mar 31, 2024 |
20,585.00 |
| Dec 31, 2023 |
-1,024.00 |
| Sep 30, 2023 |
-4,699.00 |
| Jun 30, 2023 |
28,823.00 |
| Mar 31, 2023 |
-39,196.00 |
| Dec 31, 2022 |
32,987.00 |
| Sep 30, 2022 |
15,733.00 |
| Jun 30, 2022 |
-15,634.00 |
| Mar 31, 2022 |
7,869.00 |
| Dec 31, 2021 |
-31,737.00 |
| Sep 30, 2021 |
-5,463.00 |
| Jun 30, 2021 |
-6,892.00 |
